Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 4
1(50.0%)
2Total
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07235579Completed

Understanding Cauda Equina Syndrome

Role: collaborator

NCT03663062Completed

ObeSity Related Colorectal Adenoma Risk

Role: collaborator

NCT03065660Phase 3Completed

Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage

Role: collaborator

NCT02542488Completed

STOPBANG As A Screening Tool for Obstructive Sleep Apnoea in Pregnancy

Role: lead

NCT00108706Phase 4Unknown

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

Role: lead

All 5 trials loaded